Effects of a Progestin on Frequent and/or Prolonged Bleeding With Nexplanon™

Stopped early · Phase 4 · Has a placebo group

Conditions studied: Birth Control, Contraception, Implant, Breakthrough Bleeding, Uterine Bleeding

In brief

Effects of norethindrone acetate (NTA) in patients with Nexplanon.

Key facts

Study ID

NCT04676061

Run by

Baylor Research Institute

People needed

51

Starts

2021-02-11

Expected to finish

2023-03-10

Last updated by the study team

2024-02-02

Who can join

Age: 14 and older, up to 48. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Between the ages of 18-48
• Between ages of 14-17 with parental/guardian permission
• Women desiring placement of Nexplanon™
• Willing to keep a daily symptom calendar
• Keep appointments
• Women not desiring to become pregnant in the next 2 years

You may not qualify if…

• Known or suspected Pregnancy
• Less than 8weeks postpartum
• Menarche less than two years ago
• Current or past history of thrombosis or thromboembolic disorders
• Hepatic tumors (benign or malignant)
• Active liver disease
• Undiagnosed abnormal genital bleeding
• Undiagnosed headaches
• Known or suspected carcinoma of the breast or personal history of breast cancer
• Hypersensitivity to any of the components in Nexplanon™
• BMI greater than 40
• Depomedroxyprogesterone acetate injection in the previous 12 weeks

Where it is running

• Baylor Research Institute — Temple, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.